Last Posted: Jul 10, 2020
- The Alzheimer Precision Medicine Initiative.
Hampel Harald et al. Journal of Alzheimer's disease : JAD 2019 68(1) 1-24 - Machine Learning Models Reveal the Importance of Clinical Biomarkers for the Diagnosis of Alzheimer's Disease.
Refaee Mahmoud Ahmed et al. Studies in health technology and informatics 2020 Jun 272478-481 - Evaluation and Prediction of Early Alzheimer's Disease Using a Machine Learning-based Optimized Combination-Feature Set on Gray Matter Volume and Quantitative Susceptibility Mapping.
Kim Hyug-Gi et al. Current Alzheimer research 2020 Jun - Using Unsupervised Learning to Identify Clinical Subtypes of Alzheimer's Disease in Electronic Health Records.
Alexander Nonie et al. Studies in health technology and informatics 2020 Jun 270499-503 - Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease
NS Raghavan et al, JAMA Neurology, June 22, 2020 - Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease
S Dujardin et al, Nature Medicine, June 22, 2020 - Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer's disease.
Cacabelos Ramón et al. Expert opinion on drug metabolism & toxicology 2020 Jun - Automated MRI-Based Deep Learning Model for Detection of Alzheimer's Disease Process.
Feng Wei et al. International journal of neural systems 2020 Jun 30(6) 2050032 - Genotype concordance and polygenic risk score estimation across consumer genetic testing data.
Batra Prag et al. Annals of human genetics 2020 May - ARTIFICIAL INTELLIGENCE AND NEUROPSYCHOLOGICAL MEASURES: THE CASE OF ALZHEIMER'S DISEASE.
Battista Petronilla et al. Neuroscience and biobehavioral reviews 2020 May
.png)
No hay comentarios:
Publicar un comentario